Other News
GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth
…Creates world’s first R&D Open Lab to increase understanding of non-communicable diseases and support development of new medicines for Africa
…Significantly increases African manufacturing presence to build capacity and enhance regional self sufficiency
…Establishes 25 academic Chairs at African universities to support development of local skills and capabilities in science, engineering, public health and other related areas
…Commits to train an additional 10,000 community healthworkers across sub-Saharan Africa
LONDON – GSK today announced a series of new investments in sub-Saharan Africa designed to address pressing health needs and contribute to long-term business growth.
Speaking at the 5th EU-Africa Business Forum in Brussels, GSK CEO Sir Andrew Witty set out the company’s intent to partner with governments of African countries to help stimulate more research into chronic diseases, increase capacity by localising medicines supply and strengthen healthcare infrastructure.
This will see GSK make targeted investments of up to £130 million in Africa over the next five years, creating at least 500 jobs and contributing to the development of home-grown capabilities and skills in Africa. This builds on GSK’s existing business base in sub-Saharan Africa, which currently employs around 1,500 people in over 40 countries, including at three existing local manufacturing sites in Kenya, Nigeria and South Africa.
Speaking at the meeting, Andrew Witty said: “Today, we are setting out further steps to tackle Africa’s dual health burden of infectious and emerging non-communicable diseases and help build crucial capacity to underpin the development of the healthcare sector in the region. We have a unique opportunity to deliver meaningful social and economic value to all of the communities we work in – using our scientific expertise and our global reach to develop innovative medicines and deliver them to people who need them around the world.
“With global attention focused on how we support development beyond 2015, now is the moment for business to play a more active role in contributing to a more prosperous future in Africa, investing in infrastructure, building skills and capability to unlock human potential and create jobs. Our long-term goal is to equip Africa to discover, develop and produce the medicines required for Africa.”
Supporting the development of new medicines for Africa
GSK will invest £25 million to create the world’s first R&D Open Lab for non-communicable diseases (NCDs) in Africa. This builds on the success of GSK’s Open Lab in Tres Cantos, Spain which gives independent researchers access to GSK facilities, resources and knowledge to help them advance their own research projects into diseases of the developing world such as malaria, tuberculosis and leishmaniasis.
The new R&D Open Lab for NCDs in Africa will see GSK scientists collaborate with research and scientific centres across Africa from its hub at GSK’s Stevenage R&D facility in the UK to conduct high quality epidemiological, genetic and interventional research to increase understanding of NCDs in Africa. An independent governing board of leading scientists and clinicians will oversee the implementation of NCD research projects within a dynamic and networked open innovation environment.
The open lab aims to improve understanding of NCD variations seen in the Africa setting, which could include for example the apparent higher prevalence of treatment-resistant hypertension and aggressive breast cancers in younger women. It is hoped that these insights will inform prevention and treatment strategies and will enable researchers across academia and industry to discover and develop new medicines to address the specific needs of African patients.
The open lab will directly support the training and education of African scientific researchers who will participate in a portfolio of projects, building local expertise, creating a new generation of African NCD experts while instilling a deep vein of ‘African thinking’ within GSK’s own R&D organisation.
Forming innovative partnerships to transform medicines supply in Africa
Over the next five years, GSK will look to partner with a number of African countries to develop domestic manufacturing capacity and capability. This will see GSK invest up to £100m to expand its existing manufacturing capability in Nigeria and Kenya and build up to five new factories in Africa. The company is currently reviewing possible locations in countries including Rwanda, Ghana and Ethiopia and the selected sites will be announced in due course and subject to Government agreement.
The new facilities will be built to globally recognised good manufacturing practice (GMP) standards and will make locally relevant products such as antibiotics and respiratory and HIV medicines (on behalf of ViiV Healthcare). The initial focus will be on secondary manufacture with the aim to transfer the technology, skills and knowledge needed to enable the local manufacture of more complex products over time. The factories will create a network of localised industry and local employment for a highly skilled workforce drawn from surrounding communities.
To support the scale-up of domestic manufacturing and supply, GSK will establish up to 25 academic Chairs at local African universities in related areas such as pharmaceutical sciences, public health, engineering and logistics. These roles will facilitate the development of new courses as well as internships and student exchanges, and will be pivotal to ensuring manufacturing capability is locked into the continent to help attract further manufacturing investment.
GSK is also taking steps to improve and simplify its supply chain with the creation of regional supply hubs that will help to reduce stock shortages and local supply partnerships to enable more GSK products and medicines to reach under-served rural communities in Africa. These steps will help reduce Africa’s reliance on imported medicines, improving the security of supply and reducing production costs and transportation which in time should help contribute to lower prices.
Creating a tailored portfolio of medicines to address Africa-specific health needs GSK will also optimise its portfolio of medicines for NCDs by working in collaboration with its local partner, Aspen, and with regulators to increase the registration of medicines and vaccines in its existing portfolio, such as its Amoxil antibiotic and its Ventolin respiratory medicine, where not already available.
At the same time, the company continues to work to develop new products designed to meet the specific needs of Africa, for example through its ongoing work with partners to develop the world’s first vaccine against malaria and to create new nutritional products fortified with micro-nutrients to tackle childhood malnourishment.
Playing a part in strengthening healthcare systems
GSK will also increase its support for community health worker training, in recognition of the vital role they play in delivering basic healthcare to many communities. As part of its initiative to reinvest 20% of any profits generated in LDCs back into strengthening healthcare infrastructure in those countries, GSK is already supporting the training of 15,000 healthcare workers with its NGO partners by the end of 2014.
GSK’s commitment to healthcare worker training will now be expanded to include low- and middle-income countries in sub-Saharan Africa. Over the next three years, GSK will partner with charities to help train and upskill 10,000 community healthcare workers across Kenya, Ghana and Nigeria under the umbrella of the One Million Community Health Worker campaign, a UN-led initiative directed by Professor Jeffrey Sachs. The investment will be targeted at supporting the most remote and marginalised communities to help address healthcare inequalities that exist even in fast-growing countries.
These changes build on steps taken by GSK over the past six years to modernise its business model and help improve access to medicines in developing countries. This has seen the company cap the prices of its patented medicines at no more than 25% of developed world prices and reinvest 20% of any profit made back into training healthcare workers in the world’s poorest countries and pursue open innovation models for diseases of the developing world.
The Labour Party has commended former President Goodluck Jonathan for conceding defeat in the 2015 presidential election, saying his decision demonstrated that political power was not worth the blood of Nigerians.
The National Chairman of the Labour Party, Senator Nenadi Usman, made the statement on Tuesday in Bauchi State while speaking with journalists on the sidelines of the 2026 Goodluck Jonathan Foundation Democracy Dialogue.
SEE MORE: Court Sacks Abure, Orders INEC to Recognise Nenadi Usman-led LP Caretaker Committee
The event, organised by the Goodluck Jonathan Foundation, was themed, “Beyond Elections: Can Political Parties and the Judiciary Save African Democracy?”
Usman said Nigeria’s democracy survived the tensions surrounding the 2015 election because Jonathan chose to put the national interest above his desire to remain in office.
She said, “Nigeria’s democracy survived the doomsday predictions of bookmakers in 2015 because of President Jonathan’s concession of defeat in that year’s election, even before the final votes were tallied.”
According to her, Jonathan’s approach to politics was exceptional, particularly because he had consistently maintained that neither his election nor remaining in power was worth the blood of any Nigerian.
Usman stated, “Such a principled approach to politics had never before been witnessed on the Nigerian political horizon. Jonathan, from the inception of his presidency, consistently maintained that neither his election nor remaining in power was worth the blood of any Nigerian.”
She added that Jonathan demonstrated the sincerity of his position when the 2015 election tested his commitment to the principle.
The Labour Party chairman urged politicians preparing for the 2027 general elections to emulate Jonathan’s non-violent approach to politics, respect democratic rules and place national interest above personal ambitions.
She also questioned whether politicians seeking the presidency in 2027 would be prepared to make similar sacrifices for national unity, particularly amid inflammatory rhetoric from some political camps.
Usman further recalled the saying attributed to Warren Buffett that someone is sitting in the shade today because someone planted a tree a long time ago.
She argued that Nigerians are able to practise democracy today partly because Jonathan made sacrifices at a critical moment.
On the Labour Party’s preparations for the 2027 elections, Usman described the party as the most structured opposition political party in Nigeria.
She said the Labour Party’s relationship with the Nigeria Labour Congress and the Trade Union Congress had strengthened its political structure nationwide.
Usman claimed that the party remained the only opposition party with a realistic presence across Nigeria’s 186,000 polling units.
She said, “With the combined strength of the NLC and the TUC, both of which are constitutional members of the party, no Nigerian political party is better positioned to show the APC government the exit door than the Labour Party.”
The democracy dialogue attracted several political leaders and dignitaries, including former Presidents Olusegun Obasanjo and Goodluck Jonathan, former Vice-President Namadi Sambo, Bauchi State Governor Bala Mohammed, former Senate President Anyim Pius Anyim and Labour Party’s 2023 presidential candidate, Peter Obi.
Others included former Plateau State Governor Jonah Jang, APC Deputy National Chairman, South, Dr Ben Nwoye, and the Emir of Bauchi, Dr Rilwanu Suleiman Adamu.
The dialogue provided a platform for discussions on strengthening democratic institutions, the role of political parties and the judiciary, and preventing democratic reversals across Africa.
Nigeria has recorded another major achievement on the international stage as the Mountain Top Chorale of Mountain of Fire and Miracles Ministries (MFM) emerged champion of the 2026 World Choir Games in Helsingborg, Sweden.
The Nigerian choir clinched the gold medal in the Spiritual Category (C14), scoring an impressive 87.38 points in the competition conducted by Oluwasegun Okedunmola.
The feat was celebrated by the General Overseer of MFM, Daniel Olukoya, who described the victory as a major moment of pride for Nigeria and the ministry.
SEE MORE: Harith concludes acquisition of FMFML
In a Monday Facebook post, Olukoya wrote, “A CHAMPION’S SOUND! GOLD FOR MOUNTAIN TOP CHORALE!”
According to him, the choir secured two major honours at the 2026 competition, including the gold medal in the Spiritual Category and the overall championship in the Champions Competition.
He said the achievement went beyond music, describing it as a demonstration of “discipline, excellence, dedication, teamwork and the power of using our gifts to glorify God.”
Olukoya also commended the choristers, conductor, leadership of the choir and everyone whose sacrifices and commitment contributed to the success.
The World Choir Games, organised by Interkultur, is regarded as the world’s largest international choir competition. The 2026 edition is being held in Helsingborg from August 6 to 16.
The host organisation said about 8,500 singers from more than 40 countries are participating, with more than 160 choirs taking part in the competition, concerts and other activities.
The 2026 edition is also the first time the World Choir Games are being held in Sweden.
Mountain Top Chorale’s victory places the Nigerian choir among the top performers at the global choral event and further highlights Nigeria’s presence in international gospel and choral music.
Celebrating the achievement, Olukoya said, “From Nigeria to the world, Mountain Top Chorale has raised the banner high.”
He concluded his message by congratulating the choir and giving glory to God for the historic achievement.
Former presidential candidate of the Nigeria Democratic Congress (NDC), Peter Obi, has called on President Bola Ahmed Tinubu to resign over what he described as “failure in governance,” drawing comparisons with political accountability in other democracies following the resignation announcement of UK Prime Minister Keir Starmer.
In a statement posted on his official X account on Monday, Obi said he had followed Starmer’s resignation speech and reflected on what he described as the importance of leadership responsibility in democratic governance.
ALSO READ: UK PM Keir Starmer Resigns
“As a keen observer of global politics, my primary interest lies in examining what successful nations do right and the structural factors that cause others to lag or struggle with governance and development,” Obi said.
He noted that Starmer’s decision followed growing public dissatisfaction over economic challenges, rising cost of living, and unmet campaign promises in the United Kingdom.
Obi then drew parallels with Nigeria, recalling that before the 2015 general elections, President Bola Ahmed Tinubu had repeatedly called on then-President Goodluck Jonathan to resign over insecurity.
“During the Chibok school kidnapping incident, he demanded the immediate resignation of President Jonathan, arguing that the government had failed in its most fundamental duty of protecting lives,” Obi stated.
He also referenced campaign promises made by Tinubu during the 2023 elections, including commitments to improve electricity supply, tackle corruption, and enhance the welfare of Nigerians.
“President Bola Ahmed Tinubu made several promises, including improved electricity supply. He also challenged the electorate not to vote for him for a second term if he failed to deliver on those commitments,” Obi said.
According to him, conditions in the country have since deteriorated, with persistent power shortages, worsening insecurity, and deepening economic hardship.
“At present, however, these conditions have worsened. Electricity supply remains unreliable, insecurity has intensified in many areas, including kidnappings, and economic hardship has deepened rather than eased,” he added.
Obi further argued that other sectors, including infrastructure, transportation, and anti-corruption efforts, had also suffered setbacks, insisting that Nigeria is currently in “the worst possible condition.”
The opposition figure therefore called on President Tinubu to step down, saying such a move would promote accountability in public office.
“I, therefore, join Nigerians of goodwill in calling for the resignation of the President over monumental failure in governance,” Obi said.
He added that resignation would help foster “a political culture rooted in accountability and responsibility” and reinforce the idea that “public office is a sacred trust, not an entitlement,” stressing the need for what he called “a New Nigeria that is possible.”
JUST IN: Edo Assembly in Turmoil as Speaker Agbebaku Resigns
UAE Oil Giant Says Vessel Attacked in Hormuz Strait
NGOs Get Long-term Backing from NNPC Ltd, FIRST E&P
Arsenal Thrash Man City 3-0 in Community Shield Masterclass
Kogi Man Allegedly Sets Wife Ablaze After She Burnt His Clothes
2027: Kebbi Gov Drops Deputy, Picks New Running Mate
Trump’s Family Unveils New Cryptocurrency Platform
Senate Denies Receiving Petitions Against Tinubu’s Ambassadorial Nominees
Dangote Cement Lights Up Benue Host Communities With CSR Initiatives
Reps Recommend 3-year Jail Term For Aviation minister
Tems Sets New Record On Billboard Hot 100 Chart
